AIPLA 2025 Annual Meeting
October 30 to November 1, 2025
Location
Washington, DC, USA
To be held at the Westin Washington, DC, Downtown
Executive Committee Meeting on Tuesday October 28, 2:00 - 5:00 PM
Board of Directors Meeting on Wednesday, October 29, 10 AM - 12 Noon and Saturday, November 1, 12:30 - 4:00 PM
Board/Committee Leadership Meeting, Wednesday, October 29, 1:00 - 5:00 PM
Board/Committee Leadership Networking Event, Wednesday, October 29, 6:00 - 7:30 PM
General Programming and Social Events October 30 - November 1.
Join us as we bring IP professionals together to learn and connect. More information coming soon!
RESERVATION LINK: https://book.passkey.com/go/2025AIPLA
Group Room Rate: $319 plus applicable taxes (currently 15.95%).
Check-in: 4:00PM
Check-out: 11:00AM
Cancellation - 72 hours in advance
Cut off date for Room Reservations -- Monday, October 6, 2025.
NOTE: AIPLA does NOT engage any third party vendors to assist with room reservations. All room reservations should be made directly using the Reservation link above, or by contacting the Westin directly.
If you are interested in sponsorship or exhibiting opportunities, see the Prospectus here. Contact Lisa Beller with any questions.
Add to:
News
-
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026. -
AIPLA Comments on the Copyright Office's Proposed Fee Schedule Adjustment
May 8, 2026
Arlington, VA. May 1, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office’s Notice of Proposed Rulemaking on adjustments to its fee schedule.